Your trusted source for investing success
Trump’s policies are affecting gold. You should know what’s going on. Click here to get our FREE report.
Click here to get your free report!Discover what the experts see coming in the Age of Trump with our INN Insider's Report free of charge! Includes expert insights into Trump and his effect on mining and gold.
By Shelly Kumar
Beleave Inc. (CSE: BE) (CSE: BE.CN) (CNSX: BE) is pleased to announce that effective immediately its common shares have been approved for trading on OTCQX®, the highest tier of the OTC market, exclusively for US and international companies that undergo a rigorous financial and qualitative review. The Company’s common shares will
The Investing News Network (INN) takes a closer look at the top biotech companies listed on the NASDAQ so far this year, with a market cap between 50 and 500 million.
ImmunoPrecise announced it was awarded the first commercial humanizing antibody project from an undisclosed biotech company.
CASI Pharmaceuticals, Savara, Adverum Biotechnologies, ChromaDex Therapeutics and MannKind top the NASDAQ biotech stock list.
By Jocelyn Aspa
The Canadian marijuana sector is one of the hottest growing sectors. Here’s a look at Canadian cannabis companies for investors to consider.
Neovasc, Adaptimmune, Curis, Vericel and MannKind top the NASDAQ biotech stock list.
Here, the Investing News Network looks at publicly traded biotech companies listed on the TSX.
Delcath Systems, MannKind, Zogenix, BioLife Solutions and BioDelivery Sciences top the NASDAQ biotech stock list.
Cogentix Medical, Molecular Templates, Celldex Therapeutics, Cerus and Kura Oncology top the NASDAQ biotech stock list.
Beleave Inc. (CSE: BE) (CSE: BE.CN) (CNSX: BE) is pleased to announce that it is now beginning work on a technological development research project at Ryerson University, with the goal of developing and validating technologies that are able to quantify micronutrient and heavy metal content in the cannabis plant, in
Here is a look at 5 stocks searching for novel therapies in the quest for the growing population in the anti-aging market.
PharmaCyte Biotech appointed Dr. Linda Sher as chief medical officer.
Novavax, Agenus, Sierra Oncology, Durect and Cogentix top the NASDAQ biotech stock list.
United Cannabis Corporation acquired a majority share of Prana Therapeutics.
By Shelly Kumar
Beleave Inc. (CSE: BE) (CSE: BE.CN) (CNSX: BE) (“Beleave” or the “Company”) is pleased to be a sponsor and supporter of the Don’t Drive Hicampaign, a campaign aimed to reduce cannabis impaired driving. With legislation for legalizing marijuana progressing, the year-long Don’t Drive Hicampaign is backed by prominent sponsors including advertising agency BBDO,
Vilacto Bio announced an upgrade of its production facility was completed this week.
By Pia Rivera
Here at the Investing News Network our mission is twofold; to provide the latest news and quality education by helping you identify investment opportunities in niche markets, and helping leading companies communicate their value to investors.
By Pia Rivera
Beleave Inc. (CSE: BE) (CSE: BE.CN) (CNSX: BE) (“Beleave” or the “Company”) is pleased to announce that since receiving its cultivation license, the growing space at its facility near Hamilton, Ontario has been prepared, and rooted starting material has been planted.
By Shelly Kumar
Beleave Inc. (CNSX:BE)(“Beleave” or the “Company”) recently received its Health Canada license to cultivate cannabis, and is pleased to provide shareholders with a corporate update that includes an overview of the Company’s outlook for the remainder of the year.
“Our cultivation experts will remain committed to producing a high-quality product and,
By Pia Rivera
Beleave Inc. (CSE:BE)(CSE:BE.CN)(CNSX:BE) is pleased to announce that its wholly-owned subsidiary, First Access Medical Inc. (“FAM”), has been granted a licence to cultivate medical cannabis pursuant to the Access to Cannabis for Medical Purposes Regulations (the “ACMPR”).
Trump’s policies are affecting gold. You should know what’s going on. Click here to get our FREE report.
Click here to get your free report!Discover what the experts see coming in the Age of Trump with our INN Insider's Report free of charge! Includes expert insights into Trump and his effect on mining and gold.
